INKT

MINK THERAPEUTICS INC

INKT·603693201·US·Common Stock·Healthcare - Biotechnology

INKT (MINK THERAPEUTICS INC) is held by 13 institutional investors as of Q1 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($625,103), GEODE CAPITAL MANAGEMENT, LLC ($182,666), UBS Group AG ($160,077). Net institutional sentiment: Mixed.

13
Holders
Avg rating(5 Elite)
$1.1M
Total Value
45% (17)
Fund Consensus
5 buying - 6 selling
INKTSmart Money Verdict
View all
Held by 13 funds
5 elite
Who's Trading
InsiderRBRyan BarbaraSell $5KMar 10, 2026
InsiderRBRyan BarbaraSell $8KMar 10, 2026
InsiderRBRyan BarbaraSell $8KMar 10, 2026
InsiderRBRyan BarbaraSell $2KMar 9, 2026
InsiderRBRyan BarbaraSell $1KMar 2, 2026
InsiderRBRyan BarbaraSell $4KFeb 27, 2026
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
New
59,364$625,1030.0%+3.85%
37
Increased
17,345(+21.7%)$182,6660.0%-42.06%
19
Increased
15,202(+59.2%)$160,0770.0%-7.54%
22
New
8,287$87,2620.0%+3.85%
33
Unchanged
6,203$65,3170.0%+75.40%
0
New
2,000$21,0600.0%+3.85%
26
Unchanged
104$1,0950.0%-14.31%
0
Decreased
91(-73.0%)$9580.0%-2.39%
0
Unchanged
18$1900.0%-44.42%
0
Unchanged
16$1680.0%+73.24%
0
Unchanged
9$950.0%+75.40%
0
Unchanged
1$110.0%+22.37%
0
Decreased
1(-99.2%)$100.0%-3.63%
0
Exited
0(-100.0%)$115,9600.0%-22.34%
0
Exited
0(-100.0%)$6,3330.0%+68.89%
0
Exited
0(-100.0%)$2230.0%-6.01%
0
Exited
0(-100.0%)$450.0%-6.01%
0

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used